Rhythm Pharmaceuticals, Inc. (RYTM)
96.30
-0.31
(-0.32%)
USD |
NASDAQ |
May 07, 16:00
96.30
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals EPS Diluted (Quarterly) : -0.8348 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Sarepta Therapeutics, Inc. | -3.934 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.64M |
| Revenue (Quarterly) | 60.11M |
| Total Expenses (Quarterly) | 115.75M |
| Enterprise Value | 6.507B |
| Gross Profit Margin (Quarterly) | 88.01% |
| Profit Margin (Quarterly) | -92.56% |
| Earnings Yield | -3.26% |
| Normalized Earnings Yield | -3.245 |